Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of DNAJA3 mRNA | decreases expression | 19150397
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in decreased expression of DNAJA3 mRNA | affects cotreatment|decreases expression | 18313992
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of DNAJA3 mRNA | affects cotreatment|decreases expression | 17942748
|
D005485 |
Flutamide |
Flutamide results in increased expression of DNAJA3 mRNA | increases expression | 17702527
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJA3 mRNA | affects cotreatment|increases expression | 17183730
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of DNAJA3 mRNA | increases expression | 18301758
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in decreased expression of DNAJA3 mRNA | decreases expression | 19244175
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of DNAJA3 mRNA | increases expression | 16014739
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of DNAJA3 mRNA | affects cotreatment|decreases expression | 17942748
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of DNAJA3 mRNA | affects cotreatment|increases expression | 17183730
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of DNAJA3 mRNA | decreases expression | 19244175
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in decreased expression of DNAJA3 mRNA | affects cotreatment|decreases expression | 18313992
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.83 | 15322242 11752688 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.83 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.04 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.96 | 9612607 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.87 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.08 | 17306315 16712894 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.66 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 19460635 15238991 18177632 18316065 16609825 20603192 17157402 17507914 18775368 18940202 19232924 18985861 17688650 18558336 18396377 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.13 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.25 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.25 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.70 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.07 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
1.99 | 16507464 15276417 17306315 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.41 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 18670907 18850075 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
6.97 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.97 | 19524636 20056578 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.74 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.01 | 11677210 16105132 17110522 16919318 17333356 17681005 15861022 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.01 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 16354765 12621046 8697196 15668235 15340226 |
MESH:D003092 |
Colitis |
|
Selenium |
3.92 | 17936198 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.83 | 15322242 10048152 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.83 | 17688650 8888407 16575769 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.83 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.40 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.40 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
6.40 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
14.36 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
14.36 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
14.36 | 15040536 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.17 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.88 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.29 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.09 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.99 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.68 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.44 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.22 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.10 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
19.74 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
19.74 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
19.74 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
19.74 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.06 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.26 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.83 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.75 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.75 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.17 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.17 | 17162251 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.83 | 12579204 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
5.21 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
5.21 | 12044531 15274664 15309715 16476009 15631357 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 16221962 19176532 18467677 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 15340226 12621046 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.73 | 16490937 16863852 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
7.24 | 11141242 20032539 17530837 9296927 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
7.24 | 20032539 11363243 11698656 11141242 17358032 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.25 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.15 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.02 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 8697196 18606429 15340226 16959395 16354765 |
MESH:D017588 |
Hyperandrogenism |
|
Flutamide |
5.63 | 15356085 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18670907 18850075 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.76 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.88 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.88 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.55 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.55 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.39 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.39 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.99 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
3.88 | 12579204 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
4.52 | 20370541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.17 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.47 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.47 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.47 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.58 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.58 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.58 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.17 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.68 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
7.68 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.44 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.97 | 17306315 15276417 19931552 16712894 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.97 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
4.97 | 11062179 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
4.97 | 18800350 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.83 | 15318939 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.04 | 16487513 19082730 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.83 | 15107826 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
6.01 | 17358032 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.27 | 18803445 18765137 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.14 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.21 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.18 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.11 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.11 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.80 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.57 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.57 | 8888407 16359493 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.46 | 15276417 17306315 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.06 | 15087411 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Flutamide |
5.11 | 15356085 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.98 | 11222880 11118676 11896295 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.98 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flutamide |
2.73 | 3169114 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.73 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.73 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.71 | 11422049 12752131 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.69 | 9296927 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.29 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.81 | 16876388 3137016 15475178 11044598 11738929 1511512 17978042 14763951 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.46 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.75 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.75 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.83 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.83 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.71 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
2.48 | 17696246 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.61 | 16517955 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.41 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.67 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.54 | 11723127 17306315 16452187 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.78 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.87 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.90 | 12579204 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.58 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 15869587 14671159 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |